CL2017000565A1 - Inhibidores cristalinos de bace - Google Patents
Inhibidores cristalinos de baceInfo
- Publication number
- CL2017000565A1 CL2017000565A1 CL2017000565A CL2017000565A CL2017000565A1 CL 2017000565 A1 CL2017000565 A1 CL 2017000565A1 CL 2017000565 A CL2017000565 A CL 2017000565A CL 2017000565 A CL2017000565 A CL 2017000565A CL 2017000565 A1 CL2017000565 A1 CL 2017000565A1
- Authority
- CL
- Chile
- Prior art keywords
- crystal inhibitors
- bace
- bace crystal
- inhibitors
- tetrahydropirrolo
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Pyridine Compounds (AREA)
- Soil Working Implements (AREA)
Abstract
<p>COMPUESTO N-[3-[(4AR,7AS)-2-AMIMO-6-(5-FLUOROPIRIMIDIN-2-IL)-4,4A,5,7-TETRAHIDROPIRROLO[3,4-D][1,3]TIAZIN-7A-IL]-4-FLUORO-FENIL]-5-METOXI-PIRAZIN-2-CARBOXAMIDA CRISTALINO, INHIBIDOR DE BACE; COMPOSICION FARMACEUTICA QUE LO COMPRENDE Y USO EN EL TRATAMIENTO DEL ALZHEIMER.</p>
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP14382347 | 2014-09-15 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CL2017000565A1 true CL2017000565A1 (es) | 2017-11-10 |
Family
ID=51688001
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CL2017000565A CL2017000565A1 (es) | 2014-09-15 | 2017-03-08 | Inhibidores cristalinos de bace |
Country Status (40)
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI574969B (zh) * | 2015-01-30 | 2017-03-21 | 美國禮來大藥廠 | 甲苯磺酸鹽 |
| TWI798751B (zh) | 2016-07-01 | 2023-04-11 | 美商美國禮來大藥廠 | 抗－N3pGlu類澱粉β肽抗體及其用途 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PE20091438A1 (es) * | 2008-01-18 | 2009-09-26 | Eisai Randd Man Co Ltd | Derivados fusionados de aminodihidrotiazina |
| GB201101139D0 (en) * | 2011-01-21 | 2011-03-09 | Eisai Ltd | Fused aminodihydrothiazine derivatives |
| JO3143B1 (ar) * | 2012-04-03 | 2017-09-20 | Lilly Co Eli | مركبات تتراهيدرو بيرولو ثيازين |
| TWI593692B (zh) * | 2013-03-12 | 2017-08-01 | 美國禮來大藥廠 | 四氫吡咯并噻嗪化合物 |
-
2015
- 2015-09-01 TW TW104128850A patent/TWI570127B/zh not_active IP Right Cessation
- 2015-09-02 AR ARP150102802A patent/AR101739A1/es unknown
- 2015-09-08 CA CA2957043A patent/CA2957043A1/en not_active Abandoned
- 2015-09-08 SG SG11201701637YA patent/SG11201701637YA/en unknown
- 2015-09-08 EA EA201790238A patent/EA201790238A1/ru unknown
- 2015-09-08 HU HUE15763800 patent/HUE044386T2/hu unknown
- 2015-09-08 KR KR1020177006755A patent/KR101915419B1/ko active IP Right Grant
- 2015-09-08 CN CN201580049355.2A patent/CN106661054B/zh not_active Expired - Fee Related
- 2015-09-08 CR CR20170058A patent/CR20170058A/es unknown
- 2015-09-08 NZ NZ728660A patent/NZ728660A/en not_active IP Right Cessation
- 2015-09-08 US US15/504,398 patent/US9828390B2/en not_active Expired - Fee Related
- 2015-09-08 RS RS20190614A patent/RS58756B1/sr unknown
- 2015-09-08 JP JP2017514410A patent/JP6353977B2/ja not_active Expired - Fee Related
- 2015-09-08 TR TR2019/08358T patent/TR201908358T4/tr unknown
- 2015-09-08 SI SI201530717T patent/SI3194408T1/sl unknown
- 2015-09-08 AP AP2017009781A patent/AP2017009781A0/en unknown
- 2015-09-08 AU AU2015318256A patent/AU2015318256B2/en not_active Ceased
- 2015-09-08 MX MX2017003415A patent/MX2017003415A/es unknown
- 2015-09-08 BR BR112017002586A patent/BR112017002586A2/pt not_active Application Discontinuation
- 2015-09-08 TN TN2017000065A patent/TN2017000065A1/en unknown
- 2015-09-08 PL PL15763800T patent/PL3194408T3/pl unknown
- 2015-09-08 UA UAA201701773A patent/UA119987C2/uk unknown
- 2015-09-08 EP EP15763800.8A patent/EP3194408B1/en active Active
- 2015-09-08 ES ES15763800T patent/ES2733326T3/es active Active
- 2015-09-08 MA MA39432A patent/MA39432B1/fr unknown
- 2015-09-08 DK DK15763800.8T patent/DK3194408T3/da active
- 2015-09-08 PT PT15763800T patent/PT3194408T/pt unknown
- 2015-09-08 WO PCT/US2015/048788 patent/WO2016043996A1/en active Application Filing
- 2015-09-08 PE PE2017000258A patent/PE20170674A1/es unknown
- 2015-09-08 LT LTEP15763800.8T patent/LT3194408T/lt unknown
-
2017
- 2017-01-30 IL IL250350A patent/IL250350A0/en unknown
- 2017-02-02 ZA ZA2017/00823A patent/ZA201700823B/en unknown
- 2017-02-22 SV SV2017005392A patent/SV2017005392A/es unknown
- 2017-02-27 CO CONC2017/0001927A patent/CO2017001927A2/es unknown
- 2017-03-08 CL CL2017000565A patent/CL2017000565A1/es unknown
- 2017-03-14 EC ECIEPI201715682A patent/ECSP17015682A/es unknown
- 2017-03-14 DO DO2017000070A patent/DOP2017000070A/es unknown
- 2017-03-15 PH PH12017500492A patent/PH12017500492A1/en unknown
-
2019
- 2019-05-27 HR HRP20190961TT patent/HRP20190961T1/hr unknown
- 2019-06-12 CY CY20191100609T patent/CY1121709T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA201790649A1 (ru) | Бензилзамещенные индазолы в качестве ингибиторов bub 1 | |
| UY37381A (es) | Compuestos que inhiben proteasas 3c y 3cl y métodos de uso de los mismos | |
| CL2016002027A1 (es) | Ciclopropilamina como inhibidor de la lsd1 | |
| MA48994A (fr) | Isoquinoléines utilisées en tant qu'inhibiteurs de hpk1 | |
| EA201890949A1 (ru) | СЛОЖНОЭФИРНЫЕ ИНГИБИТОРЫ АЦЕТИЛ-КоА-КАРБОКСИЛАЗЫ И ВАРИАНТЫ ИХ ПРИМЕНЕНИЯ | |
| EA201790170A1 (ru) | Терапевтические соединения-ингибиторы | |
| EA201890926A1 (ru) | ТРИАЗОЛОВЫЕ ИНГИБИТОРЫ АЦЕТИЛ-КоА-КАРБОКСИЛАЗЫ И ВАРИАНТЫ ИХ ПРИМЕНЕНИЯ | |
| EA201691916A1 (ru) | Биарильные ингибиторы киназы | |
| EA201790998A1 (ru) | Иммуннорегуляторные агенты | |
| CL2016001231A1 (es) | Compuestos de inhibidor de autotaxina | |
| MA41291A (fr) | Dérivés de la pyrrolotriazinone et de l'imidazotriazinone en tant qu'inhibiteurs de la protéase spécifique de l'ubiquitine n° 7 (usp7) pour le traitement d'un cancer | |
| EP3452029A4 (en) | INDOLEAMINE 2,3-DIOXYGENASE INHIBITORS AND METHODS OF USE | |
| EA201692338A1 (ru) | Соединения 5-хлор-дифторметоксифенил-пиразолопиримидина, представляющие собой ингибиторы янус-киназы | |
| EP3452030A4 (en) | INHIBITORS OF INDOLEAMINE-2,3-DIOXYGENASE AND METHOD FOR THEIR USE | |
| CL2016003422A1 (es) | Inhibidores de demetilasa-1 específico de lisina | |
| EA201691421A1 (ru) | Гетероарилы и их применение | |
| MX2020005213A (es) | Inhibidores de proteina cinasa 2 activada por proteina cinasa activada por mitogeno (mk2) y sus usos. | |
| MA39248B1 (fr) | Anticorps anti-jagged1 et procédés d'utilisation correspondants | |
| CL2015002897A1 (es) | Inhibidores de bace1 | |
| EP3452451A4 (en) | INDOLEAMINE 2,3-DIOXYGENASE INHIBITORS AND METHODS OF USE | |
| SG10201808940WA (en) | Nox inhibitor and nfкb inhibitor containing methoxyflavone | |
| EP3448522A4 (en) | NOVEL SUBSTITUTED IMIDAZOPYRIDIN COMPOUNDS AS INHIBITORS OF INDOLAMINE-2,3-DIOXYGENASE AND / OR TRYPTOPHANE-2,3-DIOXYGENASE | |
| MX2017013875A (es) | Ciertos inhibidores de la proteína quinasa. | |
| CL2016002839A1 (es) | Derivados de carboxamida | |
| CL2016002151A1 (es) | Derivados de piridazina para uso en la prevención o el tratamiento de un trastorno atáxico |